The National Institute for Health and Care Excellence (NICE) are doing an appraisal of belimumab (Benlysta) to produce new guidance for its use in the treatment of adults with SLE in England.
LUPUS UK is a registered consultee (stakeholder) and will be submitting evidence. To help with this and to learn more about the views of our community, we have set up an anonymous online survey.
The survey should take approximately 15 minutes to complete. If you are a UK patient with a diagnosis of SLE or care for someone with the disease, please share your experiences and views with us. You can access the survey by following this link.
